# Clinical Impact of Dedicated MR Staging of Ovarian Cancer

> **NCT03399344** · NA · UNKNOWN · sponsor: **The Netherlands Cancer Institute** · enrollment: 270 (estimated)

## Conditions studied

- Ovarian Cancer

## Interventions

- **OTHER:** MRI

## Key facts

- **NCT ID:** NCT03399344
- **Lead sponsor:** The Netherlands Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-04-13
- **Primary completion:** 2022-04-01
- **Final completion:** 2022-07-01
- **Target enrollment:** 270 (ESTIMATED)
- **Last updated:** 2018-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03399344

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03399344, "Clinical Impact of Dedicated MR Staging of Ovarian Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03399344. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*